End-to-end respiratory Strados Labs offers a full-spectrum respiratory endpoint solution for clinical trials, including cough monitoring, spirometry, FeNO, lung sounds, and respiratory eCOA, indicating a potential one-stop-shop for trial measurement needs.

Post-acquisition expansion Recent acquisition of NuvoAir assets and clinical trial business signals rapid scale in capabilities and customer reach, creating upsell opportunities to existing NuvoAir clients and a broader addressable market.

Strategic collaborations Partnerships with Beth Israel Deaconess Medical Center and collaborations with Trialogics position Strados as a trusted data and trial solutions provider, suggesting joint sales motions with research centers and CROs.

Industry engagement Active participation in ATS conferences and related pulmonary research shows strong market visibility and credibility, offering openings for speaking engagements, sponsored studies, and trials with larger pharma companies.

Growth through wearables Development of wearables for chronic respiratory diseases indicates an opportunity to cross-sell continuous monitoring solutions to ongoing studies and potential expansion into real-world evidence programs with COPD and asthma cohorts.